CoChat

MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research

Rae, James M., Creighton, Chad J., Meck, Jeanne M., Haddad, Bassem R., Johnson, Michael D. · 2007 · Breast Cancer Research and Treatment

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background The tissue of origin of the cell line MDA-MB-435 has been a matter of debate since analysis of DNA microarray data led Ross et al. (2000, Nat Genet 24(3):227-235) to suggest they might be of melanocyte origin due to their similarity to melanoma cell lines. We have previously shown that MDA-MB-435 cells maintained in multiple laboratories are of common origin to those used by Ross et al. and concluded that MDA-MB-435 cells are not a representative model for breast cancer. We could not determine, however, whether the melanoma-like properties of the MDA-MB-435 cell line are the result of misclassification or due to transdifferention to a melanoma-like phenotype.Methods We used karyotype, comparative genomic hybridization (CGH), and microsatalite polymorphism analyses, combined with bioinformatics analysis of gene expression and single nucleotide polymorphism (SNP) data, to test the hypothesis that the MDA-MB-435 cell line is derived from the melanoma cell line M14.Results We show that the MDA-MB-435 and M14 cell lines are essentially identical with respect to cytogenetic characteristics as well as gene expression patterns and that the minor differences found can be explained by phenotypic and genotypic clonal drift.Conclusions All currently available stocks of MDA-MB-435 cells are derived from the M14 melanoma cell line and can no longer be considered a model of breast cancer. These cells are still a valuable system for the study of cancer metastasis and the extensive literature using these cells since 1982 represent a valuable new resource for the melanoma research community.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10549-006-9392-8

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 376

Metadata

Authors
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D.
Affiliations
  • University of Michigan (US)
  • Georgetown University Medical Center (US)
Corresponding author
Rae, James M.
Venue
Breast Cancer Research and Treatment
Published
2006-09-27
Volume
104
Issue
1
Pages
13-19
ISSN
  • 0167-6806 (ISSN-L)
  • 1573-7217
OpenAlex
W1980757374
Cited by
374
References
19
Citations by year
2025: 2 · 2024: 8 · 2023: 15 · 2022: 4 · 2021: 9 · 2020: 10 · 2019: 7 · 2018: 13 · 2017: 13 · 2016: 10 · 2015: 15 · 2014: 24 · 2013: 19 · 2012: 23
FWCI
17.91
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Breast Cancer Research and Treatment (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Breast Cancer Research Foundation
  • National Institutes of Health (5u01gm061373-10)
  • National Cancer Institute
  • National Institute of General Medical Sciences (U-O1 GM61373)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
cell line derivation, melanocyte origin, transdifferentiation, karyotype, gene expression profiling, metastasis
MeSH terms
Breast Neoplasms, DNA, Neoplasm, Female, Humans, Melanoma, Neoplasm Proteins, Skin Neoplasms, Gene Expression, DNA Fingerprinting, Polymorphism, Single Nucleotide, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.